CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells.

Nature Biotechnology
Ibrahim C KurtJ Keith Joung

Abstract

CRISPR-guided DNA cytosine and adenine base editors are widely used for many applications1-4 but primarily create DNA base transitions (that is, pyrimidine-to-pyrimidine or purine-to-purine). Here we describe the engineering of two base editor architectures that can efficiently induce targeted C-to-G base transversions, with reduced levels of unwanted C-to-W (W = A or T) and indel mutations. One of these C-to-G base editors (CGBE1), consists of an RNA-guided Cas9 nickase, an Escherichia coli-derived uracil DNA N-glycosylase (eUNG) and a rat APOBEC1 cytidine deaminase variant (R33A) previously shown to have reduced off-target RNA and DNA editing activities5,6. We show that CGBE1 can efficiently induce C-to-G edits, particularly in AT-rich sequence contexts in human cells. We also removed the eUNG domain to yield miniCGBE1, which reduced indel frequencies but only modestly decreased editing efficiency. CGBE1 and miniCGBE1 enable C-to-G edits and will serve as a basis for optimizing C-to-G base editors for research and therapeutic applications.

References

Dec 17, 2014·Nature Biotechnology·Shengdar Q TsaiJ Keith Joung
Jun 23, 2015·Nature·Benjamin P KleinstiverJ Keith Joung
May 21, 2017·BMC Genomics·Cong GuoTimothy E Reddy
Jul 31, 2018·Nature Biotechnology·Jason M GehrkeJ Keith Joung
Sep 1, 2018·Science·Hiroshi NishimasuOsamu Nureki
Oct 17, 2018·Nature Reviews. Genetics·Holly A Rees, David R Liu
Feb 28, 2019·Nature Biotechnology·Kendell ClementLuca Pinello
Jul 25, 2019·Nature Biotechnology·Benjamin W ThuronyiDavid R Liu
Sep 4, 2019·Nature Biotechnology·Julian GrünewaldJ Keith Joung
Sep 25, 2019·Nature Biotechnology·Heon Seok KimSangsu Bae
Mar 29, 2020·Science·Russell T WaltonBenjamin P Kleinstiver

❮ Previous
Next ❯

Citations

Sep 3, 2020·International Journal of Molecular Sciences·Ariel KantorRobert E MacLaren
Oct 21, 2020·Nature Reviews. Drug Discovery·Elizabeth M PortoGene W Yeo
Jan 1, 2021·Journal of Plant Physiology·Niklas CapdevilleHolger Puchta
Jan 16, 2021·Biochemical Society Transactions·Martin Pal, Marco J Herold
Jan 24, 2021·Methods : a Companion to Methods in Enzymology·Minh Thuan Nguyen TranAlex W Hewitt
Oct 31, 2020·Journal, Genetic Engineering & Biotechnology·Ahmad M Khalil
Jan 21, 2021·International Journal of Molecular Sciences·Brian Iaffaldano, Jakob Reiser
Feb 19, 2021·Laboratory Animals·Federico Caso, Benjamin Davies
Feb 3, 2021·Plant Biotechnology Journal·Ayako Nishizawa-Yokoi, Seiichi Toki
Mar 2, 2021·Transgenic Research·Teng-Kuei Huang, Holger Puchta
Feb 20, 2021·Frontiers in Genetics·Iuri Viotti PerisseIrina A Polejaeva
Mar 13, 2021·Nature Communications·Aaron CravensChristina D Smolke
Mar 31, 2021·Current Opinion in Structural Biology·Oliver Griesbeck
Mar 29, 2021·Methods : a Companion to Methods in Enzymology·Li YangYanhui Yang
Apr 9, 2021·Nature Methods·Samuel J Hendel, Matthew D Shoulders
Apr 9, 2021·Nature·Krishanu SahaUNKNOWN SCGE Consortium
Apr 10, 2021·Journal of Zhejiang University. Science. B·Chao LiBaohong Zhang
Mar 18, 2021·The Plant Journal : for Cell and Molecular Biology·Satoru SukegawaSeiichi Toki
Apr 7, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Annarita MiccioEdor Kabashi
May 15, 2021·Frontiers in Pharmacology·Marjolein EnsinckMarianne S Carlon
May 30, 2021·Proceedings of the National Academy of Sciences of the United States of America·Ryan A Nasti, Daniel F Voytas
Jun 2, 2021·Nucleic Acids Research·Mads Valdemar AndersonJacob Giehm Mikkelsen
Dec 6, 2020·Trends in Biotechnology·M Alejandra Zeballos C, Thomas Gaj
May 26, 2021·Gene Therapy·Janine Scholefield, Patrick T Harrison
May 28, 2021·Expert Opinion on Orphan Drugs·Ruofan Connie HanRobert E MacLaren
Jul 6, 2021·Frontiers in Microbiology·Longxiang WangDeqiang Duanmu
Jul 1, 2021·Journal of Integrative Plant Biology·Rongfang XuPengcheng Wei
Aug 4, 2021·Trends in Plant Science·Md Mahmudul HassanXiaohan Yang
Aug 8, 2021·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Yan LiJun Li
Aug 14, 2021·Frontiers in Plant Science·Mawuli K Azameti, Wadzani Palnam Dauda
Aug 19, 2021·The CRISPR Journal·Keiji Nishida, Akihiko Kondo
Aug 21, 2021·Genome Biology·Yichao LiYong Cheng
Aug 16, 2021·Molecular Genetics and Metabolism·Guillermo Aquino-Jarquin
Aug 28, 2021·International Journal of Molecular Sciences·Christopher E DenesDaniel Hesselson
Jun 27, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zhiquan LiuZhanjun Li
Sep 13, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory A Newby, David R Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
deamination
PCR
restriction digest
transfection
amplicon sequencing
Assay

Software Mentioned

ggplot
seq
ABEmax
GUIDE
CRISPResso2
R
BaseSpace
miniCGBE1

Related Concepts

Related Feeds

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
You Kyeong JeongSangsu Bae
Methods : a Companion to Methods in Enzymology
Li YangYanhui Yang
© 2021 Meta ULC. All rights reserved